Histone Deacetylase Inhibitors as Cancer Therapeutics by Steven GrantHistone Deacetylase Inhibitors as Cancer Therapeutics by Steven Grant

Histone Deacetylase Inhibitors as Cancer Therapeutics

bySteven Grant, Steven Grant

Other | December 31, 2012

Pricing and Purchase Info

$147.19 online 
$184.00 list price save 20%
Earn 736 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."

  • Provides invaluable information on the exciting and fast-moving field of cancer research
  • This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics"
  • Outstanding and original reviews
Title:Histone Deacetylase Inhibitors as Cancer TherapeuticsFormat:OtherDimensions:288 pages, 1 × 1 × 1 inPublished:December 31, 2012Publisher:Elsevier ScienceLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0123946085

ISBN - 13:9780123946089

Customer Reviews of Histone Deacetylase Inhibitors as Cancer Therapeutics

Reviews

Table of Contents

      1. Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins
      2. Mechanisms of Resistance to Histone Deacetylase Inhibitors
      3. HDAC Inhibitors: Roles of DNA Damage and Repair
      4. HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer
      5. Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity
      6. Histone Deacetylase Inhibitors and Rational Combination Therapies
      7. HDAC Inhibitors and Chaperone Function